Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,677 | 82,978 | 91,276 | 94,921 | 109,306 |
| TOTAL | $78,263 | $85,596 | $95,537 | $98,546 | $110,942 |
| Non-Current Assets | |||||
| PPE Net | 550 | 601 | 624 | 630 | 604 |
| Other Non-Current Assets | 2,632 | 2,747 | 2,890 | 2,850 | 2,646 |
| TOTAL | $3,182 | $3,348 | $3,514 | $3,480 | $3,250 |
| Total Assets | $81,445 | $88,944 | $99,051 | $102,026 | $114,192 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,953 | 8,150 | 8,637 | 7,358 | 10,130 |
| TOTAL | $8,494 | $8,672 | $9,151 | $7,864 | $10,628 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,553 | 1,689 | 1,823 | 1,954 | 2,083 |
| TOTAL | $36,572 | $36,689 | $36,823 | $36,954 | $37,083 |
| Total Liabilities | $45,066 | $45,361 | $45,974 | $44,818 | $47,711 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,396 | 27,413 | 26,998 | 26,410 | 25,729 |
| Common Shares | 28 | 27 | 27 | 26 | 26 |
| Retained earnings | -337,583 | -328,259 | -314,983 | -299,802 | -288,765 |
| TOTAL | $36,379 | $43,583 | $53,077 | $57,208 | $66,481 |
| Total Liabilities And Equity | $81,445 | $88,944 | $99,051 | $102,026 | $114,192 |